MedPath

Study to clarify the mechanism of developing hyperkalemia due to hypothyroidism in thyroidectomized patients undergoing thyroid hormone withdrawal for radioactive iodine therapy.

Not Applicable
Conditions
Thyroid cancer
Registration Number
JPRN-UMIN000034377
Lead Sponsor
agasaki University
Brief Summary

Acute hypothyroidism can cause a significant increase in the serum potassium level, which may be associated with a decreased eGFR and decreased circulating RAS.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
46
Inclusion Criteria

Not provided

Exclusion Criteria

Patients administered with diuretic drug, ACE inhibitor, ARB, or steroid hormone.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath